Top Banner
Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová
15

Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Dec 31, 2015

Download

Documents

Lydia Arnold
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Drug Reimbursement in SlovakiaRole of the Slovak Myeloma Society

Dr. Katarína Fedorová

Page 2: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Health Insurance

• Not included in the scope of social insurance

• Obligatory for every resident

• 3 Heath insurance companies - Všeobecná zdravotná poisťovňa, Dôvera, Union

• Insured person - right on health care leading to prolonging life and improving its quality -art. 40 Constitution with Act No 580/2004 Coll. on Health insurance Act No 576/2004 Coll. on Health care

Page 3: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Scope of drug reimbursement

• Reimbursed - all drugs provided in inpatient care

• In outpatient care - drugs enlisted in the List of categorized medicines

Page 4: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Categorization• Process of setting whether a drug will be reimbursed from the health

insurance and in what scope

• Categorization Committee:

– Slovak chamber of doctors– Health insurance companies – Ministry of Health

• 12 times a year

• Key factors of categorization: – Average monthly income in Slovakia two years ago = € 824– Quality- Adjusted Life Year (QALY)

Page 5: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Categorization • Drug can be:

– categorized if QALY < 24 x average monthly income – conditionally categorized if QALY = 24-35 x average

monthly income

• Drug can not be categorized if QALY >35 x average monthly income (€ 28 840)

• Exception - disease with prevalence in Slovakia lower than 1:100.000 =>NOT MYELOMA

Page 6: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Categorized = Let’s have them all?

Page 7: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Categorized drugs• Limitation of prescription

Prescribed by specialist/on his recommendation

• Limitation of indication Prescribed only in case of specified condition Prescribed only in specified departments

• Need of prior approval of HIC Provider has to submit a request

• Supplementary charge paid by patient

Page 8: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Treatment of Myeloma• Velcade (bortezomib) – categorized, limitation of prescription,

limitation of indication, prior approval of HIC needed, – no supplementary charge

• Revlimid (lenalidomide) - categorized, limitation of prescription, limitation of indication, prior approval of HIC needed– no supplementary charge

• Imnovid (Pomalidomide) – not categorized Slovak Myeloma Society sends application to health insurance

companies in behalf of a patient - currently not successful– Patients on Imnovid – gift from Celgene to a hospital pharmacy

• Thalidomide Celgene – not categorized

Page 9: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Slovak Myeloma Society

• Early diagnostics of myeloma

=> Raising Awareness Campaign

• Seminars for GPs, neurologists, orthopedists • Distribution of “Diagnostic Tool” • Questionnaires for myeloma patients and hematologists

• Access to treatment

=> Statements on reimbursement

• Adherence to treatment

=> Project DIALOG = Education and Counseling - www.mydialog.sk • Interactive web page with online medical and legal counselling • Magazine “Spravodaj”• Brochures on myeloma, nursing care, legal issues• Webinars

Page 10: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Not just work!

Page 11: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Fun in Slovakia

Page 12: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Fun in Slovakia

Page 13: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Fun in Slovakia

Page 14: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Fun in Slovakia

Page 15: Drug Reimbursement in Slovakia Role of the Slovak Myeloma Society Dr. Katarína Fedorová.

Thank you for your attention

[email protected]

www.myelom.sk

facebook/mnohopocetnymyelom